STOCK TITAN

Pro-Dex (PDEX) discloses CEO cash bonus and new restricted shares

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Pro-Dex, Inc. reported compensation actions and shareholder voting results. The Compensation Committee granted restricted common shares under its 2016 Equity Incentive Plan to non-employee directors and select employees, including 1,000 restricted shares to CFO Alisha K. Charlton, vesting in equal installments over five years, generally contingent on continued employment.

The Committee also approved a discretionary cash bonus to CEO Richard L. Van Kirk of $30,830, equal to the value of 1,000 shares based on the Nasdaq Capital Market closing price on November 20, 2025, to be paid in the next bi-weekly pay period. At the 2025 Annual Meeting, all director nominees were elected, shareholders ratified the company’s independent registered public accounting firm, approved on an advisory basis the compensation of Named Executive Officers and chose an annual advisory vote on that pay, and approved an additional proposal.

Positive

  • None.

Negative

  • None.
false 0000788920 0000788920 2025-11-20 2025-11-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 20, 2025

 

PRO-DEX, INC.

(Exact name of registrant as specified in charter)

 

Colorado 0-14942 84-1261240
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification Number)

 

2361 McGaw Avenue

Irvine, California 92614

(Address of principal executive offices, zip code)

 

(949) 769-3200

(Registrant’s telephone number including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value PDEX NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company    

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 
 

 

 
 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Grant of Restricted Shares Awards

 

On November 20, 2025, the Compensation Committee of the Board of Directors of Pro-Dex, Inc. (the “Company”) approved the grant of restricted common shares under the Company’s 2016 Equity Incentive Plan to the Company’s non-employee directors and to select employees, including 1,000 restricted shares granted to Alisha K. Charlton, the Company’s Chief Financial Officer, vesting ratably over five years.

 

The restricted shares were granted pursuant to Restricted Shares Award Agreements (the “Award Agreements”), which contain terms and provisions customary for awards of this type, including that, in most instances, the employee must continue to be employed by the Company as of the applicable vesting date. A copy of the form of Award Agreement was attached as Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 25, 2024. The foregoing description of the Award Agreements is qualified in its entirety by reference to the complete text of the form of Award Agreement.

 

Compensation of Chief Executive Officer

 

On November 20, 2025, the Compensation Committee of the Board of Directors of Company approved a discretionary cash bonus to Richard L. Van Kirk, the Company’s Chief Executive Officer, of $30,830, which was calculated as the value of 1,000 shares of our common stock based on the closing sales price on the Nasdaq Capital Market on November 20, 2025. The bonus will be paid in cash in the next bi-weekly pay period with a pay date of November 26, 2025.

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On November 20, 2025, the Company held its 2025 Annual Meeting of Shareholders (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders voted on three proposals and two advisory votes set forth below. The proposals and advisory votes are described in detail in the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on October 7, 2025 (the “Proxy Statement”).

 

  1. To elect Raymond E. Cabillot, Angelita R. Domingo, William J. Farrell III, David C. Hovda, Katrina M.K. Philp, Nicholas J. Swenson and Richard L. Van Kirk (the “Candidates”) to serve as members of the board of directors (“Board”) of the Company until their successors are duly elected and qualified.

 

Candidate   Votes For   Withheld   Broker Non-Votes
Raymond E. Cabillot     1,910,955       200,822       587,016  
Angelita R. Domingo     2,103,305       8,472       587,016  
William J. Farrell III     2,102,679       9,098       587,016  
David C. Hovda     1,929,218       182,559       587,016  
Katrina M.K. Philp     1,942,445       169,332       587,016  
Nicholas J. Swenson     1,893,823       217,954       587,016  
Richard L. Van Kirk     2,103,541       8,236       587,016  

 

On the basis of the foregoing votes, each of the Candidates was elected.

 

 

 
 

 

 

  2. To ratify the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026.

 

For   Against   Abstain   Broker Non-Votes
  2,692,619       4,489       1,685       —    
                             

 

On the basis of the foregoing votes, the proposal was ratified.

 

  3. To cast a non-binding advisory vote with regard to the compensation of the Company’s Named Executive Officers (as defined in the Proxy Statement) as set forth in the Proxy Statement.

 

For   Against   Abstain   Broker Non-Votes
  2,064,143       19,916       27,718       587,016  
                             

 

On the basis of the foregoing votes, the shareholders approved, on a non-binding advisory basis, the compensation of the Named Executive Officers.

 

  4. To cast a non-binding advisory vote with regard to the frequency of future advisory votes on compensation of the Company’s Named Executive Officers.

 

One Year   Two Years   Three  Years   Abstain
  2,038,224       4,565       45,377       23,611  
                             

 

On the basis of the foregoing votes, the shareholders approved, on a non-binding advisory basis, a one-year frequency on the advisory vote of the compensation of the Named Executive Officers.

 

  5. To amend the Company’s 2016 Equity Incentive Compensation Plan in order to extend its term for an additional ten years as set forth in the Proxy Statement.

 

For   Against   Abstain   Broker Non-Votes
  1,942,832       162,366       6,579       587,016  
                             

 

On the basis of the foregoing votes, the proposal was approved.

  

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit Number Description
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

 

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 21, 2025 Pro-Dex, Inc.
   
     
  By: /s/ Alisha K. Charlton
    Alisha K. Charlton
    Chief Financial Officer

 

 

 

 

FAQ

What executive equity awards did Pro-Dex (PDEX) disclose in this 8-K?

The Compensation Committee granted 1,000 restricted common shares to CFO Alisha K. Charlton under the 2016 Equity Incentive Plan, vesting ratably over five years, along with awards to non-employee directors and select employees.

What bonus did Pro-Dex (PDEX) award to its CEO and how was it calculated?

Pro-Dex’s Compensation Committee approved a discretionary cash bonus of $30,830 for CEO Richard L. Van Kirk, calculated as the value of 1,000 shares of common stock based on the Nasdaq Capital Market closing price on November 20, 2025.

When will the Pro-Dex CEO cash bonus be paid?

The $30,830 discretionary cash bonus to CEO Richard L. Van Kirk will be paid in cash in the next bi-weekly pay period, with a stated pay date of November 26, 2025.

How do the Pro-Dex restricted share awards vest for the CFO?

The 1,000 restricted shares granted to CFO Alisha K. Charlton vest ratably over five years, and in most cases require that she remain employed by the company on each applicable vesting date.

What were the key results from Pro-Dex’s 2025 Annual Meeting of Shareholders?

At the 2025 Annual Meeting, all nominated directors were elected, shareholders ratified the independent registered public accounting firm, approved on a non-binding advisory basis the compensation of Named Executive Officers, selected a one-year frequency for the say-on-pay advisory vote, and approved another proposal.

Did Pro-Dex shareholders approve the executive compensation program on an advisory basis?

Yes. Shareholders approved, on a non-binding advisory basis, the compensation of the company’s Named Executive Officers, and also chose to hold this advisory vote on a one-year frequency.

Pro-Dex Inc Colo

NASDAQ:PDEX

PDEX Rankings

PDEX Latest News

PDEX Latest SEC Filings

PDEX Stock Data

141.15M
2.09M
35.94%
32.91%
7.98%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
IRVINE